U.S. Markets closed

Highly-Rated Biotech Post 106% Sales Growth In Profitable First Quarter

ALLISON GATLIN
Highly-Rated Biotech Post 106% Sales Growth In Profitable First Quarter

Ionis earnings of 62 cents a share and $288 million in sales beat first-quarter views on Thursday. On an adjusted basis, earnings were 89 cents per share. Ionis stock slid at the close.